Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the

Rupesh Dash1, Belal Azab, Xue-Ning Shen

  • 1Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, 23298, USA.

Discovery Medicine
|February 1, 2011
PubMed

Insights

Gene therapy offers a promising approach for advanced prostate cancer. Novel ultrasound-targeted microbubble destruction (UTMD) enhances gene delivery, overcoming limitations of traditional adenovirus vectors for effective, site-specific treatment.

Area of Science:

  • Oncology
  • Gene Therapy
  • Biotechnology

Background:

  • Prostate cancer is a leading cause of male cancer deaths, with limited effective treatments for metastatic disease.
  • Current gene therapy approaches using adenoviruses face challenges including safety, efficiency, and targeted delivery.
  • Limitations include adenovirus serotype 5 (Ad5) infectivity issues and off-target effects due to reduced Coxsackie-adenovirus receptors (CAR) on cancer cells.

Purpose of the Study:

  • To investigate a novel targeted gene delivery system for prostate cancer therapy.
  • To overcome the limitations of conventional adenoviral vectors for systemic gene delivery.
  • To develop a site-specific gene therapy approach using ultrasound-targeted microbubble destruction (UTMD).

Main Methods:

  • Utilized ultrasound (US) contrast agents (microbubbles) for targeted delivery of therapeutic reagents, including adenoviruses (Ad).
  • Employed ultrasound-targeted microbubble destruction (UTMD) to achieve site-specific therapeutic effects.
  • Tested the novel strategy in immune-competent transgenic mouse models of prostate cancer.

Main Results:

  • The UTMD approach demonstrated potential for overcoming limitations of standard Ad5 vectors, such as CAR-dependent infection.
  • This method allows for targeted delivery of therapeutic agents, potentially reducing off-target effects and immune system elimination.
  • The strategy showed promise for enhancing gene therapy efficacy in a preclinical model.

Conclusions:

  • Ultrasound-targeted microbubble destruction (UTMD) represents a viable strategy for enhancing targeted gene therapy delivery in prostate cancer.
  • This novel approach addresses key challenges in adenoviral gene therapy, including infectivity and specificity.
  • The findings suggest a direct translational path for developing effective gene therapies for prostate cancer from laboratory research to clinical application.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...